Pharminent

Generic consistency evaluation in China: the coming paradigm shift in drug pricing and patent cliff

China is one of the largest generic drug markets in the world. As part of the drug approval reform, the ongoing generic consistency evaluation (GCE) is likely to have significant, long-lasting impacts on the market landscape, drug pricing and generic…By: Allen & Overy LLP http://www.jdsupra.com/legalnews/generic-consistency-evaluation-in-china-27347/

Filed under: Emerging Markets